Akebia Therapeutics Free Cash Flow (Quarterly) Insights

Akebia Therapeutics Inc (AKBA)

1.395 -0.10 (-6.38%) USD | NASDAQ | May 07, 16:00

1.41 +0.02 (+1.08%) After-Hours: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-2.308M
September 30, 2023	-7.167M
June 30, 2023	3.629M
March 31, 2023	-17.54M
December 31, 2022	-54.68M
September 30, 2022	33.80M
June 30, 2022	-30.66M
March 31, 2022	-21.73M
December 31, 2021	-62.81M
September 30, 2021	-56.27M
June 30, 2021	-63.14M
March 31, 2021	-70.80M
December 31, 2020	-31.10M
September 30, 2020	-27.19M
June 30, 2020	37.18M
March 31, 2020	-89.59M
December 31, 2019	-92.36M
September 30, 2019	8.46M
June 30, 2019	-40.34M
March 31, 2019	-139.86M
December 31, 2018	-74.53M
September 30, 2018	-12.77M

Date	Value
June 30, 2018	8.823M
March 31, 2018	-20.63M
December 31, 2017	-16.83M
September 30, 2017	-55.21M
June 30, 2017	24.22M
March 31, 2017	-9.955M
December 31, 2016	95.62M
September 30, 2016	-29.50M
June 30, 2016	-28.20M
March 31, 2016	17.32M
December 31, 2015	-22.98M
September 30, 2015	-9.146M
June 30, 2015	-12.14M
March 31, 2015	-8.547M
December 31, 2014	-9.224M
September 30, 2014	-5.64M
June 30, 2014	-6.698M
March 31, 2014	-6.15M
December 31, 2013	-4.921M
September 30, 2013	-2.944M
June 30, 2013	-1.957M
March 31, 2013	-1.530M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-92.36M

Minimum

Dec 2019

37.18M

Maximum

Jun 2020

-30.77M

Average

-30.66M

Median

Jun 2022

Free Cash Flow (Quarterly) Benchmarks